SEC Form 4 · accession 0001209191-17-041253

Adverum Biotechnologies, Inc. · ADVM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Chief Medical Officer

Period of report

Jun 19, 2017

Accepted (ET)

Jun 21, 2017 · 6:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001501756

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 19, 2017	A	150,000	$0.00	A	150,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$2.90	Jun 19, 2017	A	213,000	A	—	Jun 18, 2027	Common Stock	213,000	213,000	D

F1Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock of the Issuer for each one (1) RSU upon the vesting thereof. Such RSUs vest with respect to twenty-five percent (25%) of the shares subject thereto on each anniversary of June 19, 2017 (the "Vesting Commencement Date"), such that all of the shares subject to the RSUs shall be vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
F2Twenty-five percent (25%) of the total shares subject to the option vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/48 of the total shares subject to the option shall vest and become exercisable each month thereafter, such that all of the shares subject to the option shall be vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.